1. Home
  2. ELWT vs ELTX Comparison

ELWT vs ELTX Comparison

Compare ELWT & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elauwit Connection Inc.

ELWT

Elauwit Connection Inc.

HOLD

Current Price

$3.05

Market Cap

47.5M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

SELL

Current Price

$1.43

Market Cap

45.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ELWT
ELTX
Founded
2002
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.5M
45.6M
IPO Year
2025
2014

Fundamental Metrics

Financial Performance
Metric
ELWT
ELTX
Price
$3.05
$1.43
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $13.00
AVG Volume (30 Days)
15.2K
★ 303.3K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
18.37
★ 39.29
EPS
★ N/A
N/A
Revenue
★ $21,618,000.00
$2,301,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$111.37
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 154.48
N/A
52 Week Low
$2.70
$1.25
52 Week High
$9.72
$16.00

Technical Indicators

Market Signals
Indicator
ELWT
ELTX
Relative Strength Index (RSI) 20.92 37.50
Support Level N/A $1.25
Resistance Level $7.99 $1.98
Average True Range (ATR) 0.50 0.19
MACD -0.07 0.00
Stochastic Oscillator 8.53 28.12

Price Performance

Historical Comparison
ELWT
ELTX

About ELWT Elauwit Connection Inc.

Elauwit Connection Inc is a provider of broadband Internet networks for the multifamily and student housing property sector. It designs, installs, operates, and maintains new fiber-optic and WiFi networks throughout each contracted property. Once installed, property owners begin selling Internet connectivity over Elauwit's network directly to their residents at monthly prices and terms of their choosing. Elauwit, in turn, provides all resident activation, onboarding, customer support, and network monitoring and maintenance services in exchange for a fixed monthly fee based on the number of units in the property times a monthly per-unit wholesale price. Its contracts with property owners generally have five to eight-year terms. Geographically, the company mainly operates in the U.S.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: